Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry

Extract
Pulmonary embolism (PE) is a condition in which thrombus, usually embolised from the veins of the pelvis or lower limbs, obstructs the pulmonary arterial vascular bed. The incidence of PE is estimated at 60–70 per 100 000 per year [1] with a 1-year mortality of 15% [2, 3]. In survivors, patency of the pulmonary vasculature is restored, in most patients, within the first few months [4]. However, pulmonary emboli may not resolve and patients may also develop a chronic obstructing microvasculopathy [5, 6].

Source: European Respiratory Journal - March 14, 2024 Category: Respiratory Medicine Authors: Durrington, C., Hurdman, J. A., Elliot, C. A., Maclean, R., Van Veen, J., Saccullo, G., De-Foneska, D., Swift, A. J., Smitha, R., Hill, C., Thomas, S., Dwivedi, K., Alabed, S., Wild, J. M., Charalampopoulos, A., Hameed, A., Rothman, A. M. K., Watson, L., Tags: Pulmonary vascular disease Original Articles: Pulmonary vascular disease Source Type: research